FRANKLIN LAKES, N.J., Dec. 28, 2010 /PRNewswire/ — Medco Health
Solutions, Inc., (NYSE:
MHS) today announced that URAC, one of the nation’s leading
independent health care quality evaluators, has accredited Medco’s
Pharmacy Benefit Management and Drug Therapy Management (DTM)
programs, recognizing the company’s commitment to clinical quality
and accountability to customers.
(Logo: http://photos.prnewswire.com/prnh/20100609/MEDCOLOGO)
URAC conducted an extensive review evaluating more than 400
standards at Medco’s Franklin Lakes, N.J., headquarters, as well
individual call centers and the Medco Therapeutic Resource
Centers® (TRCs). URAC surveyors evaluated a range of services
such as Medco’s RationalMed® patient safety system and its drug
utilization review system. Medco’s DTM programs include the TRCs
– which provides access to Medco Specialist Pharmacists who
are trained in helping patients with specific chronic and complex
conditions – as well as the company’s call center and
front-end pharmacies.
Medco Specialist Pharmacists are changing the practice of
pharmacy in the TRCs by offering patients with chronic diseases
– such as asthma, diabetes, cancer, HIV, depression,
cardiovascular disease or high cholesterol – focused and
personalized care that is specific to their condition.
Medco’s research subsidiary, the Medco Research
Institute™, is presenting and publishing data that
demonstrates how specialized and personalized pharmacy intervention
can help identify potential issues and improve outcomes for
patients managing a chronic condition.
“Medco is leading a mission to make medicine smarter by
advancing the field of pharmacy on multiple fronts. We are
focused on advancing the skills of our clinicians, on leveraging
technology
‘/>”/>
